Home Tools
Log in
Cart

DPP-4

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs, usually prescribed for people with type 2 diabetes.
Cat No. product name
T2316 Omarigliptin Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
T7133 Anagliptin Anagliptin is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
T7369L Gemigliptin Tartrate(911637-19-9 free base) Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombina...
T0191 Linagliptin Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
T23358 Sitagliptin phosphate Sitagliptin is a dipeptidyl peptidase-4 (DPP4) inhibitor.
T7369 Gemigliptin Gemigliptin is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.)
T6237 Trelagliptin Trelagliptin is a highly specific and long-acting DPP-4 inhibitor.
T0178 Saxagliptin hydrate Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
T11526 DPP-IV-IN-2 DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (DPIV) (IC50s: 0.1 and 0.95 μM).
T6192 Alogliptin Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
T15079 DBPR108 DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
T25340 Diprotin A Diprotin A is a dipeptidyl aminopeptidase IV antagonist isolated from Bacillus cereus BMF673-RF1.
T6999 Teneligliptin hydrobromide Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-...
T2401 Alogliptin Benzoate Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may...
T1502 Vildagliptin Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiet...
T12710 Retagliptin Phosphate Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
T4042 Talabostat mesylate Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation ...
T6203 Saxagliptin Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
T0242 Sitagliptin Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or...
T2296 Trelagliptin succinate Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
T16838 Saikogenin A Saikogenin A is a dipeptidyl peptidase-4 inhibitor.
T0242L Sitagliptin phosphate monohydrate Sitagliptin phosphate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
T11248 Evogliptin tartrate Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
T1581 Picolamine Picolamine acts as a potential inhibitor of DPP-4.
T1366 3-Pyridylacetic acid hydrochloride 3-Pyridylacetic acid hydrochloride is an organic compund.
Omarigliptin
T2316
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
Anagliptin
T7133
Anagliptin is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
Gemigliptin Tartrate(911637-19-9 free base)
T7369L
Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombina...
Linagliptin
T0191
Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
Sitagliptin phosphate
T23358
Sitagliptin is a dipeptidyl peptidase-4 (DPP4) inhibitor.
Gemigliptin
T7369
Gemigliptin is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.)
Trelagliptin
T6237
Trelagliptin is a highly specific and long-acting DPP-4 inhibitor.
Saxagliptin hydrate
T0178
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
DPP-IV-IN-2
T11526
DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (DPIV) (IC50s: 0.1 and 0.95 μM).
Alogliptin
T6192
Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.
DBPR108
T15079
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
Diprotin A
T25340
Diprotin A is a dipeptidyl aminopeptidase IV antagonist isolated from Bacillus cereus BMF673-RF1.
Teneligliptin hydrobromide
T6999
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-...
Alogliptin Benzoate
T2401
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may...
Vildagliptin
T1502
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiet...
Retagliptin Phosphate
T12710
Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
Talabostat mesylate
T4042
Talabostat mesylate is an orally active, selective inhibitor of dipeptidyl peptidases IV (DPP4, IC50: 0.18 nM), including tumor-associated fibroblast activation ...
Saxagliptin
T6203
Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.
Sitagliptin
T0242
Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or...
Trelagliptin succinate
T2296
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
Saikogenin A
T16838
Saikogenin A is a dipeptidyl peptidase-4 inhibitor.
Sitagliptin phosphate monohydrate
T0242L
Sitagliptin phosphate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
Evogliptin tartrate
T11248
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and s...
Picolamine
T1581
Picolamine acts as a potential inhibitor of DPP-4.
3-Pyridylacetic acid hydrochloride
T1366
3-Pyridylacetic acid hydrochloride is an organic compund.